| 1 | Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyalinemembrane disease: bronchopulmonary dysplasia [J]. N Engl J Med, 1967, 276(7): 357-368. | 
																													
																						| 2 | Baraldi E, Carraro S, Filippone M. Bronchopulmonary dysplasia: definitions and long-term respiratory outcome [J]. Early Hum Dev, 2009, 85(10 Suppl): S1-S3. | 
																													
																						| 3 | Hara F, Tatebe J, Watanabe I, et al. Molecular hydrogen alleviates cellular senescence in endothelial cells [J]. Circ J, 2016, 8(9): 2037-2046. | 
																													
																						| 4 | Dole M, Wilson FR, Fife WP. Hyperbaric hydrogen therapy: a possible treatment for cancer [J]. Science, 1975, 190(4210): 152-154. | 
																													
																						| 5 | Gharib B, Hanna S, Abdallahi OM, et al. Anti-inflammatory properties of molecular hydrogen: investigation on parasite-induced liver in-flammation [J]. CR Acad Sci Ⅲ, 2001, 324(8): 719-724 | 
																													
																						| 6 | Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a thera-peutic antioxidant by selectively reducing cytotoxic oxygen radicals [J]. Nat Med, 2007, 13: 688-694 | 
																													
																						| 7 | Upadhyay D, Kamp DW. Asbestos-induced pulmonary toxicity: role of DNA damage and apoptosis [J]. Exp Biol Med, 2003, 228(6): 650-659. | 
																													
																						| 8 | Monte LF, Silva Filho LV, Miyoshi MH, et al. Bronchopulrnonary dysplasia [J]. Pediatr, 2005, 81(2): 99-110. | 
																													
																						| 9 | Palomino MA, Morgues M, Martinez F. Management of infants with chronic lung disease of prematurity in Chile [J]. Early Hum Dev, 2005, 81(2): 143-149. | 
																													
																						| 10 | Li J, Wei K. Management of infants with chronic lung disease of prematurity in China [J]. Early Hum Dev, 2005, 81(2): 151-154. | 
																													
																						| 11 | Rush MG, Hazinski TA. Current therapy of bronchopulmonary dysplasia [J]. Clin Perinatol, 1992, 19(3): 563-590. | 
																													
																						| 12 | Smith J. An update on bronchopulmonary dysplasia; is there a relationship to the development of childhood asthma? [J]. Med Hyotheses, 2003, 61(4): 495-502. | 
																													
																						| 13 | Gore A, Muralidhar M, Espey MG, et al. Hyperoxia sensing: from molecular mechanisms to significane in disease [J]. J Immunotoxicol, 2010, 7(4): 239-254. | 
																													
																						| 14 | Bhandari V. Molecular mechanissms of hyperoxia-induced acute lung injury [J]. Front Biosci, 2008, 1(13): 6653-6661. | 
																													
																						| 15 | Chang YS, Choi SJ, Sung DK, et al. In tratracheltransplantation of human umbilicalcord blood-derivedme senchymal stem cells dose-depenently attenuates hyperoxia-induced lung injury in neonatal rats [J]. Cell Transplant, 2011, 20(11-12): 1843-1854. | 
																													
																						| 16 | Suzuki Y, Nishio K, Takesita K, et al. Effect of steroid on hyperoxia induced ICAM-1 experssion in pulmony endothelial cell [J]. Am J Physiol Lung Cell Mol Physiol, 2000, 278(2): 245-252. | 
																													
																						| 17 | Muramatsu Y, Ito M, Oshima T, et al. Hydrogen-rich water ameliorates bronchopulmonary dysplasia (BPD) in newborn rats [J]. Pediatr Pulmonol, 2016, 9(51): 928-935. | 
																													
																						| 18 | Kawamura T, Huang CS, Tochigi N, et al. Inhaled hydorgen gas therapy for prevention of prevention of lung transplant-induced ischemia/reperfusion injury in rats [J]. Transplantation, 2010, 90(12): 1344-1351. |